References to the "Company," "our," "us" or "we" refer to Macondray Capital
Acquisition Corp. I. The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with
the unaudited condensed financial statements and the notes thereto contained
elsewhere in this report. Certain information contained in the discussion and
analysis set forth below includes forward-looking statements that involve risks
and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"). We have based these forward-looking statements on our current
expectations and projections about future events. These forward-looking
statements are subject to known and unknown risks, uncertainties and assumptions
about us that may cause our actual results, levels of activity, performance or
achievements to be materially different from any future results, levels of
activity, performance or achievements expressed or implied by such
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "could," "would," "expect,"
"plan," "anticipate," "believe," "estimate," "continue," or the negative of such
terms or other similar expressions. Such statements include, but are not limited
to, possible business combinations and the financing thereof, and related
matters, as well as all other statements other than statements of historical
fact included in this Form 10-Q. Factors that might cause or contribute to such
a discrepancy include, but are not limited to, those described in our other
Securities and Exchange Commission ("SEC") filings.
Overview
This Management's Discussion and Analysis of Financial Condition and Results of
Operations has been amended and restated to give effect to the restatement of
our Post IPO Balance Sheet financial statement as of July 6, 2021. Management
identified errors made in its historical financial statement where, at the
closing of our Initial Public Offering, we improperly valued our Class A
ordinary shares subject to possible redemption. We previously determined the
Class A ordinary shares subject to possible redemption to be equal to the
redemption value of $10.10 per share of Class A ordinary share while also taking
into consideration a redemption cannot result in net tangible assets being less
than $5,000,001. Management determined that the Class A ordinary shares issued
during the Initial Public Offering can be redeemed or become redeemable subject
to the occurrence of future events considered outside of the Company's control.
Therefore, management concluded that the redemption value should include all
Class A ordinary shares subject to possible redemption, resulting in the Class A
ordinary shares subject to possible redemption being equal to their redemption
value. As a result, management has noted a reclassification error related to
temporary equity and permanent equity. This resulted in a restatement to the
initial carrying value of the Class A ordinary shares subject to possible
redemption with the offset recorded to additional paid-in capital (to the extent
available), accumulated deficit and Class A ordinary shares.
We are a blank check company incorporated as a Cayman Islands exempted company
on March 15, 2021 for the purpose of effecting a merger or mergers,
amalgamation, share exchange, share purchase, asset acquisition, reorganization
or similar business combination with one or more businesses (the "Business
Combination"). Our sponsor is Macondray, LLC, a Delaware limited liability
company ("Sponsor").
The registration statement for our Initial Public Offering ("Initial Public
Offering") was declared effective on June 30, 2021. On July 6, 2021, we
consummated the Initial Public Offering of 25,000,000 units (the "Units" and,
with respect to the Class A ordinary shares included in the Units being offered,
the "Public Shares"), at $10.00 per Unit, generating gross proceeds of $250.0
million, and incurring offering costs of approximately $14.4 million, of which
approximately $8.75 million was for deferred underwriting commissions.
Simultaneously with the closing of the Initial Public Offering, we consummated
the private placement ("Private Placement") of 6,666,667 warrants (each, a
"Private Placement Warrant" and collectively, the "Private Placement Warrants"),
at a price of $1.50 per Private Placement Warrant with the Sponsor and certain
funds and accounts managed by subsidiaries of BlackRock Inc. (collectively, the
"Anchor Investor"), generating gross proceeds of $10.0 million.
Upon the closing of the Initial Public Offering and the Private Placement,
$252.5 million ($10.10 per Unit) of the net proceeds of the Initial Public
Offering and certain of the proceeds of the Private Placement was placed in a
trust account (the "Trust Account") in
19
Table of Contents
the United States, with Continental Stock Transfer & Trust Company acting as
trustee, and will be invested in U.S. government securities, within the meaning
set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended
(the "Investment Company Act"), with a maturity of 185 days or less, or in any
money market funds meeting certain conditions of Rule 2a-7 of the Investment
Company Act, which invest only in direct U.S, government treasury obligations
until the earlier of: (i) the consummation of a Business Combination or (ii)
the distribution of the funds in the Trust Account to our shareholders, as
described below.
Subsequently, on August 5, 2021, the underwriter fully exercised the
over-allotment option, and the closing of the issuance and sale of the
over-allotment units occurred on August 10, 2021. The issuance by us of the
over-allotment units at a price of $10.00 per over-allotment unit resulted in
total gross proceeds of $37,500,000. On August 10, 2021, simultaneously with the
issuance and sale of the over-allotment units, we consummated the sale of an
additional 525,000 warrants to the Sponsor and 225,000 warrants to the Anchor
Investor, at a purchase price of $1.50 per warrant, generating gross proceeds of
$1,125,000.
If we are unable to complete a Business Combination within 18 months from the
closing of the Initial Public Offering (or 21 months from the closing of the
Initial Public Offering if we have executed a definitive agreement for a
Business Combination within 18 months from the closing of the Initial Public
Offering but have not completed a Business Combination within such 18 month
period), or January 6, 2023 or April 6, 2023, as applicable (the "Combination
Period"), we will (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than 10 business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including
interest (less up to $100,000 of interest to pay dissolution expenses and which
interest shall be net of taxes payable), divided by the number of then issued
and outstanding Public Shares, which redemption will completely extinguish
public shareholders' rights as shareholders (including the right to receive
further liquidating distributions, if any); and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of our remaining
shareholders and our board of directors, liquidate and dissolve, subject in each
case to our obligations under Cayman Islands law to provide for claims of
creditors and the requirements of other applicable law. There will be no
redemption rights or liquidating distributions with respect to our warrants,
which will expire worthless if we fail to complete our initial Business
Combination within the Combination Period.
Results of Operations
Our entire activity for the period March 15, 2021 (inception) through September
30, 2021 was for completion of the Initial Public Offering, and since our
Initial Public Offering, our activity has been limited to the search for a
prospective initial Business Combination. We will not generate any operating
revenues until the closing and completion of our initial Business Combination.
We generate non-operating income in the form of investment income from our
investments held in the Trust Account. We expect to incur increased expenses as
a result of being a public company (for legal, financial reporting, accounting
and auditing compliance), as well as for due diligence expenses.
For the period from March 15, 2021 (inception) through September 30, 2021, we
had net income of approximately $8.5 million, which was primarily comprised
change in fair value derivative warrant liabilities of $10 million partially
offset by $1.1 million of warrant related expenses and general and
administrative expenses of $0.4 million.
For the three months ended September 30, 2021, we had net income of
approximately $8.5 million, which was primarily comprised change in fair value
derivative warrant liabilities of $10 million partially offset by $1.1 million
of warrant related expenses and general and administrative expenses of $0.4
million.
Our business activities since our Initial Public Offering have consisted solely
of identifying and evaluating prospective acquisition targets for a Business
Combination.
Liquidity and Capital Resources
As of September 30, 2021, we had $831,617 in cash. Net cash used in operating
activities for the period from March 15, 2021 through September 30, 2021 was
$1,042,515. Net cash used in investing activities was $290,375,000. Net cash
provided by financing activities was $292, 249,132.
Prior to the closing of our Initial Public Offering, our liquidity needs have
been satisfied through a cash payment of $25,000 from our Sponsor in exchange
for the issuance of Founder Shares (as defined below) and a loan of $300,000
(which was repaid on July 8,
20
Table of Contents
2021) under a promissory note from our Sponsor. In addition, in order to finance
transaction costs in connection with an Initial Business Combination, our
officers, directors and initial shareholders may, but are not obligated to,
provide us Working Capital Loans. As of September 30, 2021, there were no
amounts outstanding under any Working Capital Loans.
Based on the foregoing, management believes that we will have sufficient working
capital and borrowing capacity to meet its needs through the earlier of the
consummation of a Business Combination or one year from this filing. Over this
time period, we will be using these funds held outside of the Trust Account for
paying existing accounts payable, identifying and evaluating prospective initial
Business Combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to
merge with or acquire, and structuring, negotiating and consummating the
Business Combination.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations,
operating lease obligations, purchase obligations or long-term liabilities.
Critical Accounting Policies
This management's discussion and analysis of our financial condition and results
of operations is based on our unaudited condensed financial statements, which
have been prepared in accordance with United States generally accepted
accounting principles. The preparation of these unaudited condensed financial
statements requires us to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses and the disclosure of
contingent assets and liabilities in our unaudited condensed financial
statements. On an ongoing basis, we evaluate our estimates and judgments,
including those related to fair value of financial instruments and accrued
expenses. We base our estimates on historical experience, known trends and
events and various other factors that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different
assumptions or conditions.
Fair Value of Financial Instruments
The fair value of our assets and liabilities, which qualify as financial
instruments under ASC Topic 820, "Fair Value Measurement," approximates the
carrying amounts represented in the balance sheet, primarily due to their
short-term nature. We determine fair value based on assumptions that market
participants would use in pricing an asset or liability in the principal or most
advantageous market. When considering market participant assumptions in fair
value measurements, the following fair value hierarchy distinguishes between
observable and unobservable inputs, which are categorized in one of the
following levels:
Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in
active markets.
Level 2 Inputs: Quoted prices for similar instruments in active markets and
quoted prices for identical or similar instruments in markets that are not
active and model derived valuations whose inputs are observable or whose
significant value drivers are observable.
Level 3 Inputs: Significant inputs into the valuation model are unobservable.
We do not have any recurring Level 2 or Level 3 assets or liabilities. The
carrying value of our financial instruments including its cash and accrued
liabilities approximate their fair values principally because of their
short-term nature.
Derivative Financial Instruments
We evaluate our financial instruments to determine if such instruments are
derivatives or contain features that qualify as embedded derivatives in
accordance with ASC Topic 815, "Derivatives and Hedging." Our derivative
instruments were recorded at fair value as of the closing date of the Initial
Public Offering (July 6, 2021) and will be re-valued at each reporting date,
with changes in the fair value reported in the statements of operations.
Derivative assets and liabilities are classified on the balance sheet as current
or non-current based on whether or not net-cash settlement or conversion of the
instrument could be required within 12 months of the balance sheet date. We have
determined the Public Warrants and the Private Placement Warrants are derivative
instruments.
21
Table of Contents
Warrant Instruments
We account for the Public Warrants and the Private Placement Warrants issued in
connection with the Initial Public Offering and the Private Placement in
accordance with the guidance contained in ASC Topic 815, "Derivatives and
Hedging" whereby under that provision the Public Warrants and the Private
Placement Warrants do not meet the criteria for equity treatment and must be
recorded as a liability. Accordingly, we classify the warrant instruments as
liabilities at fair value and adjust the instruments to fair value at each
reporting period. This liability will be re-measured at each balance sheet date
until the Public Warrants and the Private Placement Warrants are exercised or
expire, and any change in fair value will be recognized in our statement of
operations. The fair value of the Public Warrants and the Private Placement
Warrants will be estimated using an internal valuation model. Our valuation
model utilizes inputs and other assumptions and may not be reflective of the
price at which they can be settled. Such warrant classification is also subject
to re-evaluation at each reporting period.
Net Income Per Ordinary Share
Net income per ordinary share is computed by dividing net income by the weighted
average number of ordinary shares outstanding during the period, excluding
ordinary shares subject to forfeiture. As the Public Shares are considered to be
redeemable at fair value, and a redemption at fair value does not amount to a
distribution different than other stockholders, Class A and Class B ordinary are
presented as one class of stock in calculating net loss per share. As a result,
the calculated net loss per share is the same for Class A and Class B ordinary
shares. As of September 30, 2021, we did not have any dilutive securities and
other contracts that could, potentially, be exercised or converted into ordinary
shares and then share in the earnings of the Company. As a result, diluted
income per share is the same as basic income per share for the period presented.
Recent Accounting Pronouncements
In August 2020, the FASB issued Accounting Standards Update ("ASU") No. 2020-06,
"Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging--Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for
Convertible Instruments and Contracts in an Entity's Own Equity ("ASU
2020-06")", which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. The ASU also removes
certain settlement conditions that are required for equity-linked contracts to
qualify for the derivative scope exception, and it simplifies the diluted
earnings per share calculation in certain areas. ASU 2020-06 is effective for
the Company on January 1, 2022. Adoption of the ASU is not expected to impact
the Company's financial position, result of operations or cash flows.
Our management does not believe that any other recently issued, but not yet
effective, accounting standards if currently adopted would have a material
effect on the accompanying unaudited condensed financial statements.
Off-Balance Sheet Arrangements
As of September 30, 2021, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" and
under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for non-emerging growth companies. As a result, our financial statements may not
be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the
other reduced reporting requirements provided by the JOBS Act. Subject to
certain conditions set forth in the JOBS Act, if, as an "emerging growth
company," we choose to rely on such exemptions we may not be required to, among
other things: (1) provide an auditor's attestation report on our system of
internal controls over financial reporting pursuant to Section 404 of the
Sarbanes-Oxley Act; (2) provide all of the compensation disclosure that may be
required of non-emerging growth public companies under the Dodd-Frank Wall
Street Reform and Consumer Protection Act; (3) comply
22
Table of Contents
with any requirement that may be adopted by the Public Company Accounting
Oversight Board (United States) regarding mandatory audit firm rotation or a
supplement to the auditor's report providing additional information about the
audit and the financial statements (auditor discussion and analysis); and (4)
disclose certain executive compensation-related items such as the correlation
between executive compensation and performance and comparisons of the CEO's
compensation to median employee compensation. These exemptions will apply for a
period of five years following the completion of this offering or until we are
no longer an "emerging growth company," whichever is earlier.
© Edgar Online, source Glimpses